Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
6.77
-1.13 (-14.30%)
Mar 31, 2025, 4:00 PM EDT - Market closed

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Market Capitalization
132155--
Enterprise Value
124142--
Last Close Price
6.777.96--
Quick Ratio
0.980.980.434.71
Current Ratio
1.051.050.434.71
Return on Equity (ROE)
---442.40%-
Return on Assets (ROA)
-255.41%-255.41%-132.96%-
Return on Capital (ROIC)
---279.06%-
Buyback Yield / Dilution
-483.48%-483.48%-18.54%-
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q